Valitor- Engineering better medicines by leveraging its multi-valent biopolymer technology - podcast episode cover

Valitor- Engineering better medicines by leveraging its multi-valent biopolymer technology

Dec 13, 202258 minEp. 34
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Wesley Jackson, Ph..D., is the co-founder, President and Chief Scientific Officer of Valitor. Wes was the founding CEO and led the startup through its Series B financing where they raised over$30M to date. Valitor is a biotech startup that uses a novel protein-biopolymer conjugation technology that was licensed from the University of California, Berkeley. Professors Kevin Healy and Dave Schaffer were the inventors of the technology and ended up co-founding the startup. We talk about Wesley’s decision making process to launch the startup, the conjugation technology and the problems it is capable of solving; customer discovery process; lessons learnt from working with partners; finding product market fit; fund raising; importance of work-life balance while building a deeptech startup, a very important topic that is generally frowned upon at startups; and programs that helped Wes grow his startup, leadership transition and many other lessons. Shownotes: -  https://www.valitorbio.com - Decision making process to launch Valiant Bio - Working with faculty at UC Berkeley to spin out a technology - Multivalent Polymer conjugation for tissue localization to develop therapeutics - Customer discovery process - Speaking with physicians, feedback from grant submissions - Noise vs signal - Dissecting "No" from potential customers/investors - Speaking with potential partners: Timing and alignment - Questions to ask potential partners - Product market fit - Funding journey - Lessons learnt from grant proposal writing - Too much data: Mistakes in the pitch deck - Focus on markets - Building a biotech startup is mostly a marathon with a few sprints - Balancing life and family: Raising twins while building the startup - Doesn't make sense to burn employees as they carry. lot of institutional/intellectual memory - Role of the board and insights into independent board members - Leadership transition - Programs that helped- https://skydeck.berkeley.edu, California FAST Advisory program

For the best experience, listen in Metacast app for iOS or Android